Central adiposity measures as recommended risk factors for CV outcomes
obesity
OBESITY, PATHOLOGY, CVD, ADIPOSITY, EVENTS, TYPE 2 DIABETES
Our results showed that either WHR or WC were risk factors for MACE-3, CVD-related mortality, and all-cause mortality. Given that different measures of obesity indicate general adiposity versus specific areas of fat depots, such as central fat, this may translate to different physiological effects and therefore varied associations with different outcomes. Although reports differ, most studies suggest that central obesity, measured by WHR or WC, is a risk factor for CVD [Given the strong evidence that central adiposity can inform patients’ risk of CV events, guidelines should include detail on collecting these measures in addition to weight and BMI. It is increasingly more widely acknowledged that central adiposity can not only contribute to CV risk but also to type 2 diabetes pathology [